US0905721082 - Common Stock
BIO-RAD LABORATORIES -CL B
NYSE:BIO.B (4/18/2024, 7:04:00 PM)
279.91
-58.64 (-17.32%)
Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. The company is headquartered in Hercules, California and currently employs 8,200 full-time employees. The firm operates through two segments: Life Science and Clinical Diagnostics. Life Science segment markets and develops, manufactures and markets a portfolio of various products that serves a global customer base. The segment is focused on specific segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cellular biology and food safety. Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. Its products address specific niches within the in vitro diagnostics (IVD) test market.
BIO-RAD LABORATORIES -CL B
1000 Alfred Nobel Dr
Hercules CALIFORNIA
P: 15107247000
CEO: Norman Schwartz
Employees: 8200
Website: https://www.bio-rad.com/
Here you can normally see the latest stock twits on BIO.B, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: